Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で180.22%の成長率を示しています。
黒字転換
同社は黒字転換を果たし、最新の年間純利益はUSD 126.04Mです。%!(EXTRA int=2)
適正水準
同社の最新のPEは66.23で、過去3年間の水準と比較して適正圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は201.00M株で、前四半期比で14.69%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を18.63M株保有しています。
市場活動が低調
同社への投資家の関心は低下しており、20日間の売買回転率は0.72です。